Evidence map›Paper›PMID 18283437›Full record

ReviewPsychopharmacology2008

Controversies in translational research: drug self-administration.

Margaret Haney, Roger Spealman

Open access · bronzeAbstract readReview
In one paragraph

Review in Psychopharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed, 3 pooled it
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 3 syntheses or guidelines pooled it, 271 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Trial
  12. An fMRI-Based Neural Signature of Decisions to Smoke Cannabis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Trial
  13. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.Progress in neuro-psychopharmacology & biological psychiatry · 2012
    Trial
  20. Trial

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Margaret HaneyDepartment of Psychiatry, College of Physicians and Surgeons of Columbia University and the New York State Psychiatric Institute, 1051 Riverside Dr., Unit 120, New York, NY 10032, USA. mh235@columbia.edu
Roger Spealman
Beth Israel Deaconess Medical Center · USColumbia University · US

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WESTMORELAND, SUSAN V. · 1985 to 2011
$139.3M
PHARMACOLOGICAL TREATMENT OF MARIJUANA DEPENDENCEP50DA009236 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI KLEBER, HERBERT DAVID · 1994 to 2013
$39.4M
Nonhuman Primate Models of Reinstated Cocaine SeekingR01DA011054 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SPEALMAN, ROGER D · 1997 to 2011
$3.8M
Nonhuman Primate Models of Speedball AbuseR01DA011928 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SPEALMAN, ROGER D · 1998 to 2007
$2.5M
Medication Development for Marijuana RelapseR01DA019239 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HANEY, MARGARET · 2004 to 2008
$2.5M
mGluR5 Mechanisms in Primate Models of Cocaine AbuseR01DA017700 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SPEALMAN, ROGER D · 2004 to 2008
$1.8M
MOUSE MODELS OF CANCER, BONE DISEASE, AND LACTATIONK26RR000168 · NCRR · OHIO STATE UNIVERSITY · PI ROSOL, THOMAS J · 2000 to 2004
$547k
NCRR NIH HHS K26 RR000168NCRR NIH HHS P51 RR000168NCRR NIH HHS RR00168NIDA NIH HHS DA 09236NIDA NIH HHS DA11054NIDA NIH HHS DA11928NIDA NIH HHS DA17700NIDA NIH HHS DA 19239NIDA NIH HHS P50 DA009236NIDA NIH HHS R01 DA011054NIDA NIH HHS R01 DA011928NIDA NIH HHS R01 DA017700NIDA NIH HHS R01 DA019239
6 · The paper itself

Abstract

rationaleLaboratory animal and human models of drug self-administration are used to evaluate potential pharmacotherapies for drug abuse, yet the utility of these models in predicting clinically useful medications is variable.

objectiveThe objective of this study was to track how antagonist, agonist, and partial agonist medication approaches influence heroin and cocaine self-administration by rodents, non-human primates, and humans and to compare these results to clinical outcomes.

resultsAcross species, heroin self-administration was decreased by all three medication approaches, paralleling their demonstrated clinical utility. The heroin data emphasize the importance of assessing a medication's abuse liability preclinically to predict medication abuse and compliance and of considering subject characteristics (e.g., opioid dependence) when interpreting medication effects. For cocaine, the effects of ecopipam, modafinil, and aripiprazole were consistent in the laboratory and clinic, provided that the medications were administered repeatedly before self-administration sessions. Modafinil attenuated cocaine's reinforcing effects in the human laboratory and improved treatment outcome, while ecopipam and aripiprazole increased the reinforcing effects of cocaine and do not appear promising in the clinic.

conclusionsThe self-administration model has reliably identified medications to treat opioid dependence, and the recent data with modafinil suggest that the human laboratory model also identifies medications to treat cocaine dependence. There have been numerous false positives when subjective effects are the primary outcome measure, but not when self-administration is the outcome. Factors relevant to the predictive validity of self-administration procedures include medication maintenance and the concurrent assessment of a range of behaviors to determine abuse liability and the specificity of effect.

Indexed as

AnimalsCocaine-Related DisordersDisease Models, AnimalHeroin DependenceHumansPrimatesRodentiaSelf AdministrationSubstance-Related Disorders

Identifiers

PMID18283437
PMCPMC2731701
OpenAlexW1965528317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.